Cutting GLP-1 coverage may cost UVM Health more than it saves

UVM Health anticipates annual savings of $19 million by discontinuing coverage for GLP-1 treatments, which are used for weight management. However, critics argue this move overlooks the long-term medical cost savings that might occur when these treatments are effective. This decision raises concerns about the broader implications for employee health and potential future healthcare expenses, suggesting that the initial savings might be offset by increased healthcare costs down the line. The debate underscores the complexities of balancing immediate financial savings with long-term health benefits.